STOCK ALARM
SA
Menu
Set Alert
Demo
Go Pro
Log In
Today
My Portfolio
Find Stocks
The Market
Charts
Research
Advisor
⌘J
TBPH
(TBPH)
TBPH
Overview
Intelligence
Chart
Fundamentals
Key Metrics
Earnings
Growth
Analysts
Financials
Insiders
Institutional
More
Show Technical Panel
Show S&P 500 Navigator
Loading chart...
Key Metrics
As of
2025
• vs 2024
Annual
Quarterly
Core Metrics
Market Cap
$941.43M
+104.8%
P/E Ratio
8.89
+209.1%
P/S Ratio
8.76
+22.7%
ROE
35.69%
+211.0%
ROIC
-2.37%
+83.2%
FCF Yield
25.33%
+1081.3%
Debt/Equity
0.25
-10.3%
Current Ratio
10.93
+117.6%
Interest Coverage
-5.38x
+70.8%
Per Share
Revenue/Share
$2.14
+62.0%
Net Income/Share
$2.10
+282.2%
Operating CF/Share
$4.74
+2107.6%
Free CF/Share
$4.74
+2051.1%
Cash/Share
$6.27
+246.5%
Book Value/Share
$5.90
+64.1%
Tangible Book/Share
$5.90
+64.1%
Equity/Share
$5.90
+64.1%
Interest Debt/Share
$1.55
+44.5%
Valuation
Market Cap
$941.43M
+104.8%
Enterprise Value
$849.12M
+80.0%
P/E Ratio
8.89
+209.1%
P/S Ratio
8.76
+22.7%
P/OCF Ratio
3.95
+109.9%
P/FCF Ratio
3.95
+110.2%
P/B Ratio
3.17
+21.2%
P/TB Ratio
3.17
+21.2%
EV/Sales
7.90
+7.9%
EV/EBITDA
-109.83
-795.4%
Profitability
Earnings Yield
11.25%
+191.6%
FCF Yield
25.33%
+1081.3%
ROE
35.69%
+211.0%
ROIC
-2.37%
+83.2%
Return on Tangible Assets
21.81%
+236.9%
Capital Allocation
CapEx/OCF
0.02%
+100.6%
CapEx/Revenue
0.04%
-92.4%
CapEx/Depreciation
0.01
-91.9%
SBC/Revenue
17.19%
-48.3%
Balance Sheet
Debt/Equity
0.25
-10.3%
Debt/Assets
0.16
+10.5%
Net Debt/EBITDA
11.94
+3918.7%
Current Ratio
10.93
+117.6%
Interest Coverage
-5.38x
+70.8%
Income Quality
2.25
+1001.8%
Efficiency
Days Sales Outstanding
324 days
-16.4%
Days Payables Outstanding
170 days
Days Inventory
0 days
Receivables Turnover
1.12x
+19.6%
Payables Turnover
2.15x
Inventory Turnover
0.00x
Special Valuations
Graham Number
$16.71
Graham Net-Net
$3.94
+594.1%
Explore More
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
Home
Screener
Alerts
Search
More
Theravance Biopharma, Inc.
(TBPH)
$16.22
▼
-0.29 (-1.76%)
Chart
Share
Post on X
TBPH
Theravance Biopharma, Inc.
(TBPH)
NASDAQ
$16.22
▼
-0.29 (-1.76%)
Chart Studio
Share
TBPH